Antibiotic-Associated Diarrhea Treatment Market
Antibiotic-Associated Diarrhea Treatment Market Study by Oral and Injectables through Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Other Distribution Channels From 2024 to 2034
Analysis of Antibiotic-Associated Diarrhea Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Antibiotic-Associated Diarrhea Treatment Market Outlook (2024 to 2034)
The global antibiotic-associated diarrhea treatment market is analyzed to reach a valuation of US$ 1.43 billion in 2024 and further expand at a CAGR of 12.4% to end up at US$ 4.62 billion by the end of 2034.
Antibiotic-associated diarrhea (AAD) therapies are in high demand worldwide because of their widespread uses and advantages. Effective therapies are increasingly needed as long as antibiotic usage is common and AAD prevalence is rising. These treatments not only aid with discomfort relief but also with hospital stay reduction, problem avoidance, and overall patient outcomes improvement.
Because they balance the gut flora again, AAD treatments-probiotics and prebiotics in particular-are becoming more popular. Beyond AAD, its uses appear promising for several gastrointestinal illnesses, immune system enhancement, and even mental wellness via the gut-brain axis.
Several manufacturers are using certain tactics to boost the acceptance of AAD therapies around the world. More money is spent on clinical research to verify effectiveness and broaden the list of authorized uses. Certain firms are creating innovative product formulations, including synbiotic combos or targeted-release probiotics, to stand out from the competition.
The goal of marketing initiatives is to inform patients and healthcare professionals about the value of gut health and the function of AAD therapies. Manufacturers are using social media and digital platforms to spread the word and offer conveniently accessible information.
Important strategies include collaborations with medical facilities and participation in treatment protocols. To reach a wider market, several businesses are investigating direct-to-consumer methods, including providing over-the-counter versions of their products.
The need for AAD therapies is anticipated to continue rising as awareness and research expand, spurring more innovation and market expansion in this crucial healthcare area.
| Report Attribute | Detail |
|---|---|
| Antibiotic-Associated Diarrhea Treatment Market Size (2024E) | US$ 1.43 Billion |
| Forecasted Market Value (2034F) | US$ 4.62 Billion |
| Global Market Growth Rate (2024 to 2034) | 12.4% CAGR |
| North America Market Value (2024E) | US$ 499.5 Million |
| Mexico Market Value (2034F) | US$ 149.7 Million |
| Drug Stores Segment Growth Rate (2024 to 2034) | 11.7% CAGR |
| Canada Market Value (2034F) | US$ 224.7 Million |
| Key Companies Profiled | Merck & Co Inc.; TECHLAB; Manav Drugs PVT Ltd.; Pfizer Inc.; Aurobindo Pharma Limited; CutisPharma Inc.; Cosmo Pharmaceuticals; Johnson & Johnson |
Antibiotics are generally recommended by doctors for bacterial infections. While fighting the infectious bacteria, antibiotics kill the good bacteria present in the intestine as well, which results in diarrhea. As antibiotics kill the good bacteria, it disrupts the balance of the intestine and increases the bad bacteria's resistance to antibiotics.
Therefore, it is said that Antibiotic-associated diarrhea is a side effect of antibiotics. It has been observed that the majority of the time, diarrhea ceases post the course of the antibiotic; however, it becomes serious and leads to hospitalization in many cases.
Probiotics, such as yogurts and fermented products are advised as they help in the functioning of the digestive system. Antibiotics that commonly cause Antibiotic-associated diarrhea include cephalosporins, such as cefixime, cefpodoxime, penicillins, and clostridium. In addition, attributed to the high dosage of a broad spectrum of antibiotics, hospitalized patients also suffer from diarrhea.
At times, Antibiotic-associated diarrhea occurs 2 to 8 weeks after the antibiotics have been discontinued. When a patient is observed to be suffering from diarrhea, the first line of treatment includes maintaining an adequate amount of water and discontinuing the drug. The patient is given electrolytes and fluid as a supportive treatment for the improvement of his health.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Antibiotic-Associated Diarrhea Treatment Market: Drivers and Restraints
Market growth has increased due to the availability of over-the-counter drugs, which has contributed to an increase in the prevalence of Antibiotic-associated diarrhea Moreover, several patients opt for self-prescribed drugs for the treatment of the disease rather than consulting a doctor, which is driving the global market.
A rise in the technology and development of online pharmacies is also making patients opt for self-treatments. The overall Antibiotic-associated diarrhea treatment market is pushed by the increasing demand for growing expenditure on healthcare and patient safety. However home remedies and treatment decreases the growth of the market as per the antibiotic-associated diarrhea treatment industry outlook.
Antibiotic-Associated Diarrhea Treatment Market: Overview
The global market for antibiotic-associated diarrhea treatment is expected to witness high growth over the forecast period. The majority of the drugs are introduced in the generic market and thus, high competition exists among local and regional players. Antibiotic-associated diarrhea occurs due to an imbalance in the intestine as the good bacteria are killed due to high dosage or discontinuation of antibiotics, which causes intestinal imbalance.
In Fact.MR published antibiotic-associated diarrhea treatment industry analysis, the drugs are divided based on the route of administration and distribution channel. The market for treatment of antibiotic-associated diarrhea is expected to increase with a rise in the patient pool opting for drugs.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Antibiotic-Associated Diarrhea Treatment Market: Regional Outlook
Geographically, the global market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be a dominant market in the global market, owing to the high prevalence of diseases and usage of antibiotics.
Further, the market in North America will rise, due to advancements in technology and strict regulations about patient care and safety in the region.
The market in Asia Pacific is evaluated to grow with a significant CAGR due to the expansion of product offerings by key players, as stated in the antibiotic-associated diarrhea treatment industry analysis.
In addition, government initiatives in the region aimed at providing better healthcare facilities to the population contribute to the growth of antibiotic-associated diarrhea treatment. Europe is expected to hold a significant share of the global market throughout the forecast period.
Antibiotic-Associated Diarrhea Treatment Market: Market Participants
The global market for antibiotic-associated diarrhea treatment is highly fragmented. As opined in the antibiotic-associated diarrhea treatment industry outlook, some of the key players operating in the global market include:
- Merck & Co Inc.
- TECHLAB
- Manav Drugs PVT Ltd
- Pfizer Inc.
- Aurobindo Pharma Limited
- CutisPharma Inc.
- Cosmo Pharmaceuticals
- Johnson & Johnson
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers an exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Peru
- Rest of Latin America
- Europe
- EU-4 (Germany, France, Italy, Spain)
- United Kingdom
- BENELUX (Belgium, Netherlands, Luxemburg)
- NORDIC (Norway, Denmark, Iceland, Sweden)
- Eastern Europe (Poland, Ukraine, Czech Rep., Others)
- Rest of Europe
- CIS & Russia
- Japan
- APEJ
- Greater China
- India
- Korea
- ASEAN Countries
- Rest of APEJ
- Middle East & Africa
- GCC Countries
- Turkey
- Iran
- Israel
- South Africa
- Rest of MEA
Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Segmentation of the Antibiotic-Associated Diarrhea Treatment Market Research
-
By Route of Administration :
- Oral
- Injectable
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
-
By Region :
- North America
- Latin America
- Eastern Europe
- Western Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Route Of Administration
- 6.2. Distribution Channel
- 7. Global Market Analysis and Forecast, By Route Of Administration
- 7.1. Oral
- 7.2. Injectable
- 8. Global Market Analysis and Forecast, By Distribution Channel
- 8.1. Hospital Pharmacy
- 8.2. Retail Pharmacies
- 8.3. Drug Stores
- 8.4. Online Pharmacy
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Route Of Administration and Distribution Channel for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. CutisPharma, Inc
- 19.2. Pfizer Inc
- 19.3. Manav Drugs Pvt Ltd
- 19.4. Aurobindo Pharma Limited
- 19.5. AdvaCare Pharma
- 19.6. Cadila Pharmaceuticals Ltd
- 19.7. GlaxoSmithKline Pharmaceuticals Ltd
- 19.8. Teva Pharmaceutical Industries Ltd.
- 19.9. Others
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Route Of Administration
Table 3: Global Market US$ Mn Forecast by Distribution Channel
Table 4: North America Market US$ Mn Forecast by Country
Table 5: North America Market US$ Mn Forecast by Route Of Administration
Table 6: North America Market US$ Mn Forecast by Distribution Channel
Table 7: Latin America Market US$ Mn Forecast by Country
Table 8: Latin America Market US$ Mn Forecast by Route Of Administration
Table 9: Latin America Market US$ Mn Forecast by Distribution Channel
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Route Of Administration
Table 12: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Route Of Administration
Table 15: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 16: East Asia Market US$ Mn Forecast by Country
Table 17: East Asia Market US$ Mn Forecast by Route Of Administration
Table 18: East Asia Market US$ Mn Forecast by Distribution Channel
Table 19: South Asia & Pacific Market US$ Mn Forecast by Country
Table 20: South Asia & Pacific Market US$ Mn Forecast by Route Of Administration
Table 21: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Route Of Administration
Table 24: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 17: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 18: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 20: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 21: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which are the major factors driving antibiotic-associated diarrhea treatment market growth?
Demand for growing expenditure on healthcare and patient safety drives the market.
Who are the key players in the global market?
CutisPharma, Inc., Pfizer Inc., Manav Drugs Pvt. Ltd., Aurobindo Pharma Limited, and AdvaCare Pharma are some key market players.
Antibiotic-Associated Diarrhea Treatment Market